Report Detail

Request for Sample of this report

Other Global Novel Drug Delivery Systems Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4656221
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 148 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Novel Drug Delivery Systems market size was valued at US$ 25850 million in 2024 and is forecast to a readjusted size of USD 28980 million by 2031 with a CAGR of 1.7% during review period.
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
This report is a detailed and comprehensive analysis for global Novel Drug Delivery Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Novel Drug Delivery Systems market size and forecasts, in consumption value ($ Million), 2020-2031
Global Novel Drug Delivery Systems market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Novel Drug Delivery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Novel Drug Delivery Systems market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Novel Drug Delivery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Novel Drug Delivery Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Novel Drug Delivery Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Market segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by players, this report covers
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Novel Drug Delivery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Novel Drug Delivery Systems, with revenue, gross margin, and global market share of Novel Drug Delivery Systems from 2020 to 2025.
Chapter 3, the Novel Drug Delivery Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Novel Drug Delivery Systems market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Novel Drug Delivery Systems.
Chapter 13, to describe Novel Drug Delivery Systems research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Novel Drug Delivery Systems by Type
    • 1.3.1 Overview: Global Novel Drug Delivery Systems Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Novel Drug Delivery Systems Consumption Value Market Share by Type in 2024
    • 1.3.3 Liposomes
    • 1.3.4 PEGylated Proteins & Polypeptides
    • 1.3.5 Polymer Nanoparticle
    • 1.3.6 Protein–drug Conjugates
    • 1.3.7 Others
  • 1.4 Global Novel Drug Delivery Systems Market by Application
    • 1.4.1 Overview: Global Novel Drug Delivery Systems Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals & Clinic
    • 1.4.3 Cancer Treatment Centers
    • 1.4.4 Others
  • 1.5 Global Novel Drug Delivery Systems Market Size & Forecast
  • 1.6 Global Novel Drug Delivery Systems Market Size and Forecast by Region
    • 1.6.1 Global Novel Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Novel Drug Delivery Systems Market Size by Region, (2020-2031)
    • 1.6.3 North America Novel Drug Delivery Systems Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Novel Drug Delivery Systems Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Novel Drug Delivery Systems Market Size and Prospect (2020-2031)
    • 1.6.6 South America Novel Drug Delivery Systems Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Novel Drug Delivery Systems Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Amgen
    • 2.1.1 Amgen Details
    • 2.1.2 Amgen Major Business
    • 2.1.3 Amgen Novel Drug Delivery Systems Product and Solutions
    • 2.1.4 Amgen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Amgen Recent Developments and Future Plans
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Novel Drug Delivery Systems Product and Solutions
    • 2.2.4 Teva Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Teva Recent Developments and Future Plans
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Novel Drug Delivery Systems Product and Solutions
    • 2.3.4 Roche Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Roche Recent Developments and Future Plans
  • 2.4 UCB (Union Chimique Belge)
    • 2.4.1 UCB (Union Chimique Belge) Details
    • 2.4.2 UCB (Union Chimique Belge) Major Business
    • 2.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product and Solutions
    • 2.4.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 UCB (Union Chimique Belge) Recent Developments and Future Plans
  • 2.5 Celgene
    • 2.5.1 Celgene Details
    • 2.5.2 Celgene Major Business
    • 2.5.3 Celgene Novel Drug Delivery Systems Product and Solutions
    • 2.5.4 Celgene Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Celgene Recent Developments and Future Plans
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Novel Drug Delivery Systems Product and Solutions
    • 2.6.4 Merck Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Merck Recent Developments and Future Plans
  • 2.7 Gilead Sciences
    • 2.7.1 Gilead Sciences Details
    • 2.7.2 Gilead Sciences Major Business
    • 2.7.3 Gilead Sciences Novel Drug Delivery Systems Product and Solutions
    • 2.7.4 Gilead Sciences Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Gilead Sciences Recent Developments and Future Plans
  • 2.8 Sanofi
    • 2.8.1 Sanofi Details
    • 2.8.2 Sanofi Major Business
    • 2.8.3 Sanofi Novel Drug Delivery Systems Product and Solutions
    • 2.8.4 Sanofi Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Sanofi Recent Developments and Future Plans
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Novel Drug Delivery Systems Product and Solutions
    • 2.9.4 Pfizer Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Pfizer Recent Developments and Future Plans
  • 2.10 Takeda
    • 2.10.1 Takeda Details
    • 2.10.2 Takeda Major Business
    • 2.10.3 Takeda Novel Drug Delivery Systems Product and Solutions
    • 2.10.4 Takeda Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Takeda Recent Developments and Future Plans
  • 2.11 Bausch&Lomb
    • 2.11.1 Bausch&Lomb Details
    • 2.11.2 Bausch&Lomb Major Business
    • 2.11.3 Bausch&Lomb Novel Drug Delivery Systems Product and Solutions
    • 2.11.4 Bausch&Lomb Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Bausch&Lomb Recent Developments and Future Plans
  • 2.12 Samyang Biopharmaceuticals
    • 2.12.1 Samyang Biopharmaceuticals Details
    • 2.12.2 Samyang Biopharmaceuticals Major Business
    • 2.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product and Solutions
    • 2.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Samyang Biopharmaceuticals Recent Developments and Future Plans
  • 2.13 Johnson & Johnson
    • 2.13.1 Johnson & Johnson Details
    • 2.13.2 Johnson & Johnson Major Business
    • 2.13.3 Johnson & Johnson Novel Drug Delivery Systems Product and Solutions
    • 2.13.4 Johnson & Johnson Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.14 TOLMAR
    • 2.14.1 TOLMAR Details
    • 2.14.2 TOLMAR Major Business
    • 2.14.3 TOLMAR Novel Drug Delivery Systems Product and Solutions
    • 2.14.4 TOLMAR Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 TOLMAR Recent Developments and Future Plans
  • 2.15 Astellas
    • 2.15.1 Astellas Details
    • 2.15.2 Astellas Major Business
    • 2.15.3 Astellas Novel Drug Delivery Systems Product and Solutions
    • 2.15.4 Astellas Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Astellas Recent Developments and Future Plans
  • 2.16 AMAG Pharmaceuticals
    • 2.16.1 AMAG Pharmaceuticals Details
    • 2.16.2 AMAG Pharmaceuticals Major Business
    • 2.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
    • 2.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 AMAG Pharmaceuticals Recent Developments and Future Plans
  • 2.17 AbbVie
    • 2.17.1 AbbVie Details
    • 2.17.2 AbbVie Major Business
    • 2.17.3 AbbVie Novel Drug Delivery Systems Product and Solutions
    • 2.17.4 AbbVie Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 AbbVie Recent Developments and Future Plans
  • 2.18 Dr Reddy
    • 2.18.1 Dr Reddy Details
    • 2.18.2 Dr Reddy Major Business
    • 2.18.3 Dr Reddy Novel Drug Delivery Systems Product and Solutions
    • 2.18.4 Dr Reddy Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Dr Reddy Recent Developments and Future Plans
  • 2.19 AstraZeneca
    • 2.19.1 AstraZeneca Details
    • 2.19.2 AstraZeneca Major Business
    • 2.19.3 AstraZeneca Novel Drug Delivery Systems Product and Solutions
    • 2.19.4 AstraZeneca Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 AstraZeneca Recent Developments and Future Plans
  • 2.20 Aspen
    • 2.20.1 Aspen Details
    • 2.20.2 Aspen Major Business
    • 2.20.3 Aspen Novel Drug Delivery Systems Product and Solutions
    • 2.20.4 Aspen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Aspen Recent Developments and Future Plans
  • 2.21 Acrotech Biopharma
    • 2.21.1 Acrotech Biopharma Details
    • 2.21.2 Acrotech Biopharma Major Business
    • 2.21.3 Acrotech Biopharma Novel Drug Delivery Systems Product and Solutions
    • 2.21.4 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.21.5 Acrotech Biopharma Recent Developments and Future Plans
  • 2.22 TWi Pharmaceuticals
    • 2.22.1 TWi Pharmaceuticals Details
    • 2.22.2 TWi Pharmaceuticals Major Business
    • 2.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
    • 2.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2020-2025)
    • 2.22.5 TWi Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Novel Drug Delivery Systems Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Novel Drug Delivery Systems by Company Revenue
    • 3.2.2 Top 3 Novel Drug Delivery Systems Players Market Share in 2024
    • 3.2.3 Top 6 Novel Drug Delivery Systems Players Market Share in 2024
  • 3.3 Novel Drug Delivery Systems Market: Overall Company Footprint Analysis
    • 3.3.1 Novel Drug Delivery Systems Market: Region Footprint
    • 3.3.2 Novel Drug Delivery Systems Market: Company Product Type Footprint
    • 3.3.3 Novel Drug Delivery Systems Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Novel Drug Delivery Systems Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Novel Drug Delivery Systems Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Novel Drug Delivery Systems Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Novel Drug Delivery Systems Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Novel Drug Delivery Systems Consumption Value by Type (2020-2031)
  • 6.2 North America Novel Drug Delivery Systems Market Size by Application (2020-2031)
  • 6.3 North America Novel Drug Delivery Systems Market Size by Country
    • 6.3.1 North America Novel Drug Delivery Systems Consumption Value by Country (2020-2031)
    • 6.3.2 United States Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Novel Drug Delivery Systems Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Novel Drug Delivery Systems Consumption Value by Type (2020-2031)
  • 7.2 Europe Novel Drug Delivery Systems Consumption Value by Application (2020-2031)
  • 7.3 Europe Novel Drug Delivery Systems Market Size by Country
    • 7.3.1 Europe Novel Drug Delivery Systems Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 7.3.3 France Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Novel Drug Delivery Systems Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Novel Drug Delivery Systems Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Novel Drug Delivery Systems Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Region
    • 8.3.1 Asia-Pacific Novel Drug Delivery Systems Consumption Value by Region (2020-2031)
    • 8.3.2 China Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 8.3.5 India Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Novel Drug Delivery Systems Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Novel Drug Delivery Systems Consumption Value by Type (2020-2031)
  • 9.2 South America Novel Drug Delivery Systems Consumption Value by Application (2020-2031)
  • 9.3 South America Novel Drug Delivery Systems Market Size by Country
    • 9.3.1 South America Novel Drug Delivery Systems Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Novel Drug Delivery Systems Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Novel Drug Delivery Systems Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Novel Drug Delivery Systems Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Country
    • 10.3.1 Middle East & Africa Novel Drug Delivery Systems Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Novel Drug Delivery Systems Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Novel Drug Delivery Systems Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Novel Drug Delivery Systems Market Drivers
  • 11.2 Novel Drug Delivery Systems Market Restraints
  • 11.3 Novel Drug Delivery Systems Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Novel Drug Delivery Systems Industry Chain
  • 12.2 Novel Drug Delivery Systems Upstream Analysis
  • 12.3 Novel Drug Delivery Systems Midstream Analysis
  • 12.4 Novel Drug Delivery Systems Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Novel Drug Delivery Systems. Industry analysis & Market Report on Novel Drug Delivery Systems is a syndicated market report, published as Global Novel Drug Delivery Systems Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Novel Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo